Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer

This study has been completed.
Information provided by:
Millennium Pharmaceuticals, Inc. Identifier:
First received: July 10, 2003
Last updated: February 7, 2008
Last verified: February 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)